View from Brussels

Oct 01, 2015
Applied Clinical Trials
Several initiatives are focused on integrating biomarkers and personalized medicine techniques into studies.
Aug 01, 2015
Applied Clinical Trials
Officials tackle such areas as patient access and personalized medicine.
Jun 01, 2015
Applied Clinical Trials
The tone of agency’s annual report contrasts its recent candid stance on regulatory vision for Europe.
Apr 01, 2015
Applied Clinical Trials
Media rebuke of Europe’s Innovative Medicines Initiative thrusts debate into the public arena.
Feb 01, 2015
Applied Clinical Trials
While such discussions have advanced in Europe, two key omissions from the dialogue may limit any real changes.
Jan 02, 2015
Applied Clinical Trials
Patients in Europe have been increasingly vocal in their demands for engagement in drug development and regulatory processes—and they have been increasingly effective.
Dec 01, 2014
Applied Clinical Trials
In a health policy world where competition for profile is tough, a vacuum at the top is a serious disadvantage.
Oct 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Reshuffling to heavily impact life sciences policy in Europe.
Jun 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
Claims of success for pharmacovigilance are under question, but hopes are higher for new clinical trials rules.
Apr 01, 2014
Applied Clinical Trials
By Applied Clinical Trials Editors
The advent of new drugs for tuberculosis is posing some interesting challenges for regulators in Europe.
native1_300x100
lorem ipsum